A carregar...
Failure to achieve castrate level of serum testosterone during luteinizing hormone-releasing hormone agonist therapy in a patient with prostate cancer
We report the failure to achieve castrate level of serum testosterone during luteinizing hormone-releasing hormone agonist therapy in a patient with prostate cancer. A 76-year-old man was admitted to our hospital for evaluation of an elevated serum prostate specific antigen (PSA) level (191.10 ng/ml...
Na minha lista:
| Publicado no: | Anticancer Drugs |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Lippincott Williams & Wilkins
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7566291/ https://ncbi.nlm.nih.gov/pubmed/32804697 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CAD.0000000000000986 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|